Adenosine Triphosphate

Adenosine Triphosphate

SCHEMBL8980

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[P@@](=O)(O)O[P@@](=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 7/20 0.94
P2RX1 P51575 4/20 0.94
P2RX3 P56373 4/20 0.94
P2RY2 P41231 3/20 0.94
P2RX2 Q9UBL9 2/20 0.94
SRC P12931 2/20 0.94
SMN1; SMN2 Q16637 2/20 0.94
ALDH1A1 P00352 2/20 0.94
P2RX4 Q99571 1/20 0.94
RNASEL Q05823 1/20 0.88
TRPM2 O94759 2/20 0.88
MACROD2 A1Z1Q3 1/20 0.88
SIRT6 Q8N6T7 1/20 0.88
MACROD1 Q9BQ69 1/20 0.88
TAS1R3 Q7RTX0 2/20 0.83
TAS1R1 Q7RTX1 2/20 0.83
DNPH1 O43598 1/20 0.83
PRKAB2 O43741 1/20 0.83
LDHA P00338 1/20 0.83
ADRB2 P07550 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9171542 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
SCHEMBL376008 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL8979 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL12789528 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL6242713 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL18784961 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL13722152 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL13722139 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL2227081 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL20550531 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 126492 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144783-A1 COMPOSITION FOR PREVENTING OR TREATING PERIPHERAL NEUROPATHY, CONTAINING ISOQUINOLINE DERIVATIVE AS ACTIVE INGREDIENT ALTMEDICAL CO., LTD. (KR) 2026-05-28 US claimed
US-20260144839-A1 METHOD FOR ENHANCING ACTIVITY OF MITOCHONDRIA TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD. (TW) 2026-05-28 US claimed
US-20260144784-A1 COMPOSITION FOR PREVENTING OR TREATING MELAS SYNDROME, CONTAINING ISOPQUINOLINE DERIVATIVE AS ACTIVE INGREDIENT ALTMEDICAL CO., LTD. (KR) 2026-05-28 US claimed
US-20260146272-A1 ENZYMATIC SYNTHESIS OF MODIFIED NUCLEOSIDE TRIPHOSPHATE ANALOGUES ILLUMINA, INC. (US) 2026-05-28 US claimed
EP-4746880-A2 METHODS OF TREATING DILATED CARDIOMYOPATHY Regencor, Inc. (US) 2026-05-27 EP claimed
EP-4379061-B1 METHOD AND APPARATUS FOR RAPIDLY TESTING MICROORGANISM HITACHI HIGH TECH CORP (JP) 2026-05-27 EP claimed
EP-4748388-A2 STABILISING THE HUMAN SPINDLE BY KIFC1/HSET Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V. (DE) 2026-05-27 EP claimed
EP-4747390-A2 PROTEIN EXPRESSION REAGENTS Nuclera Ltd (GB) 2026-05-27 EP claimed
EP-4152609-B1 WORKING STATE ADJUSTMENT METHOD AND APPARATUS, TERMINAL AND STORAGE MEDIUM BEIJING XIAOMI MOBILE SOFTWARE CO LTD (CN) 2026-05-27 EP claimed
CN-122090127-A Deep learning-based organoid ATP non-invasive prediction method 2026-05-26 CN claimed
EP-0121254-A2 Process for determining substrate or enzymatic activity WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1984-10-10 EP claimed
US-4473496-A Intramolecularly crosslinked hemoglobin THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1984-09-25 US claimed
EP-0107400-A1 Hybrid plasmid and process for producing glutathione using said plasmid Kimura, Akira (JP) 1984-05-02 EP claimed
EP-0100022-A1 Pharmaceutical composition containing adenosine derivatives for use in treating tumours Rapaport, Eliezer (US) 1984-02-08 EP claimed
US-4427777-A Enzymatic conversion of red cells for transfusion NEW YORK BLOOD CENTER, INC. (US) 1984-01-24 US claimed
EP-0076466-A2 Novel phosphoric ester of antibiotic OA-6129 and its preparation method Sanraku Incorporated (JP) 1983-04-13 EP claimed
US-4271264-A Stabilized liquid enzyme and coenzyme compositions MEDICAL ANALYSIS SYSTEMS, INC. 1981-06-02 US claimed
US-4267195-A Dog food flavors UNIVERSITY OF TEXAS (US) 1981-05-12 US claimed
US-4247633-A Reagent for colorimetric determination of creative phosphokinase PABST BREWING COMPANY (US) 1981-01-27 US claimed
US-4056442-A RHIZOPUS ARRHIZIRS AND CANDIDA CYLINDRACEA THE DOW CHEMICAL COMPANY (US) 1977-11-01 US claimed